Impact of Cyanocobalamin and Methylcobalamin on Inflammatory Bowel Disease and the Intestinal Microbiota Composition

被引:43
|
作者
Zhu, Xuan [1 ]
Xiang, Shasha [1 ]
Feng, Xiao [1 ]
Wang, Huanhuan [2 ]
Tian, Shiyi [1 ]
Xu, Yuanyuan [1 ]
Shi, Lihua [1 ]
Yang, Lu [2 ]
Li, Mian [3 ]
Shen, Yubiao [4 ]
Chen, Jie [1 ]
Chen, Yuewen [1 ]
Han, Jianzhong [1 ]
机构
[1] Zhejiang Gongshang Univ, Sch Food Sci & Bioengn, 18 Xuezheng St, Hangzhou 310018, Zhejiang, Peoples R China
[2] Hangzhou Normal Univ, Sch Med, Hangzhou 310018, Zhejiang, Peoples R China
[3] Zhejiang Huakang Pharmaceut Co Ltd, Quzhou 324302, Zhejiang, Peoples R China
[4] Tsinghua Univ, Yangtze Delta Reg Inst, Jiaxing 314000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
cyanocobalamin; methylcobalamin; gut microbiome; inflammatory bowel disease; Enterobacteriaceae; VITAMIN-B-12; GUT; COLITIS; PATHOGENESIS; DEFICIENCY;
D O I
10.1021/acs.jafc.8b05730
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Patients with inflammatory bowel disease (IBD) are usually advised to supplement various types of vitamin B-12, because vitamin B-12 is generally absorbed in the colon. Thus, in the current study, the influence of cyanocobalamin (CNCBL) or methylcobalamin (MECBL) ingestion on IBD symptoms will be investigated. Then, whether and how the application of various cobalamins would modify the taxonomic and functional composition of the gut microbiome in mice will be examined carefully. Dextran-sulfate-sodium-induced IBD mice were treated with MECBL or CNCBL; disease activity index (DAI) scores and intestinal inflammatory conditions of mice were evaluated. Fecal samples were collected; microbiota composition was determined with a 16s rRNA analysis; functional profiles were predicted by phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt); and short-chain fatty acids were measured. The consequence of higher relative abundances of Enterobacteriaceae and isomeric short-chain fatty acids by cobalamin treatment revealed that a high concentration of CNCBL but not MECBL supplementation obviously aggravated IBD. A microbial ecosystem rich in Escherichia/Shigella and low in Lactobacillus, Blautia, and Clostridium XVIII was observed in IBD mice after a high concentration of CNCBL supplementation. In cobalamin-dependent enzymes, CNCBL was more efficient in the adenosylcobalamin system than MECBL and vice versa in the MECBL system. The distinct effects of various cobalamins were associated with the distribution and efficiency of vitamin-B-12-dependent riboswitches. CNCBL had a strong inhibitory effect on all riboswitches, especially on btuB and pocR riboswitches from Enterobacteriaceae. CNCBL aggravated IBD via enhancing the proportion of Enterobacteriaceae organisms through riboswitch and enzyme systems. The present study provides a critical reference for offering a suitable amount and type of cobalamin during a symbiotic condition.
引用
收藏
页码:916 / 926
页数:11
相关论文
共 50 条
  • [41] Composition of the colon microbiota in the individuals with inflammatory bowel disease and colon cancer
    Ceren Acar
    Sibel Kucukyildirim Celik
    H. Ozgur Ozdemirel
    Beril Erdem Tuncdemir
    Saadet Alan
    Hatice Mergen
    Folia Microbiologica, 2024, 69 : 333 - 345
  • [42] Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel Disease
    Hill, Janet E.
    Pena-Sanchez, Juan-Nicolas
    Fernando, Champika
    Freitas, Aline C.
    Gamage, Niradha Withana
    Fowler, Sharyle
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (06) : 905 - 911
  • [43] The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease
    Sha, Sumei
    Xu, Bin
    Wang, Xin
    Zhang, Yongguo
    Wang, Honghong
    Kong, Xiangyun
    Zhu, Hongwu
    Wu, Kaichun
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 75 (03) : 245 - 251
  • [44] Composition of the colon microbiota in the individuals with inflammatory bowel disease and colon cancer
    Acar, Ceren
    Celik, Sibel Kucukyildirim
    Ozdemirel, H. Ozgur
    Tuncdemir, Beril Erdem
    Alan, Saadet
    Mergen, Hatice
    FOLIA MICROBIOLOGICA, 2024, 69 (02) : 333 - 345
  • [45] Gut mucosal microbiota composition in Inflammatory Bowel Disease introduced to infliximab
    Ventin-Holmberg, R.
    Lindholm, J.
    Eberl, A.
    Taina, S.
    Saavalainen, P.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 1036 - 1036
  • [46] Role of Intestinal Microbiota in Inflammatory Bowel Diseases
    Eun, Chang Soo
    INTESTINAL RESEARCH, 2013, 11 (03) : 161 - 168
  • [47] THE IMPACT OF BIOLOGICAL TREATMENT AND INFLAMMATORY BURDEN IN INFLAMMATORY BOWEL DISEASE ON THE GUT MICROBIOTA
    Caenepeel, Clara
    Vieira-Silva, Sara
    Verstockt, Bram
    Machiels, Kathleen
    Davani, Nooshin Ardeshir
    Sabino, Joao
    Ferrante, Marc
    Raes, Jeroen
    Vermeire, Severine
    GASTROENTEROLOGY, 2020, 158 (06) : S540 - S540
  • [48] Crosstalk Between the Intestinal Microbiota and the Innate Immune System in Intestinal Homeostasis and Inflammatory Bowel Disease
    Dupaul-Chicoine, Jeremy
    Dagenais, Maryse
    Saleh, Maya
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (10) : 2227 - 2237
  • [49] Dysregulation of cellular vs humoral immunity to the intestinal microbiota in inflammatory bowel disease
    Noble, A.
    Durant, L.
    Hoyles, L.
    McCartney, A. L.
    Man, R.
    Costello, S. P.
    Hendy, P.
    Reddi, D.
    Segal, J.
    Lim, D.
    Bolton, M.
    Hart, A. L.
    Carding, S. R.
    Knight, S. C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S123 - S124
  • [50] Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease
    Zhang, Ming
    Sun, Kaiji
    Wu, Yujun
    Yang, Ying
    Tso, Patrick
    Wu, Zhenlong
    FRONTIERS IN IMMUNOLOGY, 2017, 8 : 1 - 13